The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Transforming Growth Factor-β1 Prevents Glutamate Neurotoxicity in Rat Neocortical Cultures and Protects Mouse Neocortex from Ischemic Injury in vivo
Abstract
Transforming growth factor-β 1 (TGF-β 1) has been shown to be an injury-related peptide growth factor within the mammalian central nervous system. We tested whether TGF-β 1 has the capacity to protect rat neocortical neurons against excitotoxic damage in vitro and mouse neocortex against ischemic injury in vivo. After 14 days in vitro, cultured neurons from rat cerebral cortex were exposed to 1 m M l-glutamate in serum-free culture medium. The cultures received TGF-β 1 immediately after the addition of glutamate. Eighteen hours later, the cell viability of the cultures was determined using trypan blue exclusion. TGF-β 1 (1–10 ng/ml) significantly reduced the excitotoxic neuronal damage in a concentration-dependent manner. In vivo, male NMRI mice were subjected to a permanent occlusion of the left middle cerebral artery by microbipolar electrocoagulation. After 48 h, the animals received a transcardiac injection of carbon black. The area of ischemia (devoid of carbon) was restricted to the neocortex and its size was determined planimetrically by means of an image-analyzing system. The treatment with TGF-β 1 (1 μg/kg i.c.v.) at 6, 4, or 2 h prior to vessel occlusion reduced the area of ischemia by 5.3, 10.0, and 9.6%, respectively. The effect of the treatment with TGF-β 1 was statistically significant (p < 0.05 by two-way ANOVA). The present in vitro and in vivo data suggest that TGF-β 1 has the capacity to diminish the deleterious consequences of an excitotoxic or ischemic insult.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trophic factors and neuronal survival
Barde, Y.-A. (1989) · Neuron · doi:10.1016/0896-6273(89)90040-8 · Cited by 1,625
Mattson, M., Murrain, M., Guthrie, P., & Kater, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-03728.1989 · Cited by 480
Localization and actions of transforming growth factor-β s in the embryonic nervous system
Flanders, K. C., Lüdecke, G., Engels, S., Cissel, D. S., Roberts, A. B., Kondaiah, P., Lafyatis, R., Sporn, M. B., & Unsicker, K. (1991) · Development · doi:10.1242/dev.113.1.183 · Cited by 359
Amelioration of delayed neuronal death in the hippocampus by nerve growth factor
Shigeno, T., Mima, T., Takakura, K., Graham, D., Kato, G., Hashimoto, Y., & Furukawa, S. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-09-02914.1991 · Cited by 333
Cited by
Cytokines and acute neurodegeneration
Allan, S. M., & Rothwell, N. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094583 · Cited by 1,123
Inflammation and glial responses in ischemic brain lesions
Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 795
Cheng, B., Christakos, S., & Mattson, M. P. (1994) · Neuron · doi:10.1016/0896-6273(94)90159-7 · Cited by 668
Morishita, E., Masuda, S., Nagao, M., Yasuda, Y., & Sasaki, R. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00306-5 · Cited by 661
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631
Self-citationMattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475
The role of astroglia in neuroprotection
Bélanger, M., & Magistretti, P. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/mbelanger · Cited by 396
Transcriptome Profiling Reveals TGF- Signaling Involvement in Epileptogenesis
Cacheaux, L. P., Ivens, S., David, Y., Lakhter, A. J., Bar-Klein, G., Shapira, M., Heinemann, U., Friedman, A., & Kaufer, D. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0430-09.2009 · Cited by 383
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
Potentiated Necrosis of Cultured Cortical Neurons by Neurotrophins
Koh, J.-Y., Gwag, B. J., Lobner, D., & Choi, D. W. (1995) · Science · doi:10.1126/science.7725105 · Cited by 365
Reactive Astrocytes As Therapeutic Targets for CNS Disorders
Hamby, M. E., & Sofroniew, M. V. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.003 · Cited by 365
TRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE
FLANDERS, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00066-x · Cited by 364
Pathophysiology of Stroke: Lessons from Animal Models
Mergenthaler, P., Dirnagl, U., & Meisel, A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043966.46964.e6 · Cited by 325
Krieglstein, K., Suter-Crazzolara, C., Fischer, W. H., & Unsicker, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07052.x · Cited by 324
Apoptotic and antiapoptotic mechanisms in stroke
Mattson, M. P., Culmsee, C., & Yu, Z. F. (2000) · Cell and Tissue Research · doi:10.1007/s004419900154 · Cited by 318
Gregersen, R., Lambertsen, K., & Finsen, B. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200001000-00009 · Cited by 314
MATTSON, M. P., & SCHEFF, S. W. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.3 · Cited by 309
Guido, S., Sebastian, J., & Schroeter, M. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0123-7_3 · Cited by 276
Friedman, A., Kaufer, D., & Heinemann, U. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.005 · Cited by 270
Reperfusion Injury after Focal Cerebral Ischemia: The Role Inflammation and the The rapeutic Horizon
Jean, W. C., Spellman, S. R., Nussbaum, E. S., & Low, W. C. (1998) · Neurosurgery · doi:10.1097/00006123-199812000-00076 · Cited by 264
Astrocytes as a Source for Extracellular Matrix Molecules and Cytokines
Wiese, S., Karus, M., & Faissner, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00120 · Cited by 262
Henrich-Noack, P., Prehn, J. H. M., & Krieglstein, J. (1996) · Stroke · doi:10.1161/01.str.27.9.1609 · Cited by 202
Self-citationMark, R. J., Keller, J. N., Kruman, I., & Mattson, M. P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00196-0 · Cited by 167
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
Zhang, Z., Bassam, B., Thomas, A. G., Williams, M., Liu, J., Nance, E., Rojas, C., Slusher, B. S., & Kannan, S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.010 · Cited by 84
Koeglsperger, T., Li, S., Brenneis, C., Saulnier, J. L., Mayo, L., Carrier, Y., Selkoe, D. J., & Weiner, H. L. (2013) · Glia · doi:10.1002/glia.22490 · Cited by 73
“Previous studies indicated that TGF-b1 has neuroprotective effects in a variety of in vivo and in vitro model systems (Boche et al., 2003; Prehn et al., 1993a,b), although the cellular mechanisms that account for its neuroprotective effect remained largely elusive.”
BackgroundSchwab, J. M., Postler, E., Nguyen, T. D., Mittelbronn, M., Meyermann, R., & Schluesener, H. J. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00271.x · Cited by 41
Vince, V., Thil, M.-A., Gérard, A.-C., Veraart, C., Delbeke, J., & Colin, I. M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.010 · Cited by 35
“TGF-h1 exerts neuroprotective effects that have been evidenced in vitro (Prehn et al., 1993), and after neonatal axotomy in the rat (Iwasaki et al.”
BackgroundFabrizi, C., Businaro, R., Lauro, G. M., Starace, G., & Fumagalli, L. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6978 · Cited by 14
Metadata
- Authors
- Prehn, J. H. M., Backhauß, C., & Krieglstein, J.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 1993-05
- Volume
- 13
- Issue
- 3
- Pages
- 521-525
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W1982196927
- Cited by
- 226
- References
- 4
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.